Nyumbani › Ugonjwa wa Crohn › Oklahoma
Majaribio ya kliniki ya Ugonjwa wa Crohn katika jimbo la Oklahoma
Masomo 8 ya Ugonjwa wa Crohn yanatafuta washiriki katika vituo vya jimbo la Oklahoma.
Miji katika jimbo la Oklahoma
Maandishi rasmi ya utafiti (Kiingereza)
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- Digestive Disease Specialists Inc. ( Site 5117), Oklahoma City
InaajiriHatua 3
Umri 16 hadi 80 · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT06430801Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- Digestive Disease Specialists - Oklahoma /ID# 265901, Oklahoma City
InaajiriHatua 2
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 25 Sep 2026 · NCT06548542A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- Digestive Disease Specialists Inc, Oklahoma City
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 25 Sep 2026 · NCT07499232An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Central Sooner Research-Site Number: 8400094, Norman
InaajiriHatua 3
Umri 16 hadi 80 · Jinsia zote · Imesasishwa 23 Sep 2026 · NCT07184931A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
- Digestive Disease Specialists, Inc., Oklahoma City
InaajiriHatua 4
Umri 18 hadi 70 · Jinsia zote · Imesasishwa 9 Sep 2026 · NCT06045754A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
- Digestive Disease Specialists Inc, Oklahoma City
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Ago 2026 · NCT07577843A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
- The University of Oklahoma Health Sciences Center, Oklahoma City
InaajiriHatua 3
Umri 2 hadi 17 · Jinsia zote · Imesasishwa 3 Ago 2026 · NCT06100289A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- The University of Oklahoma Health Sciences Center, Oklahoma City
InaajiriHatua 3
Umri 2 hadi 17 · Jinsia zote · Imesasishwa 22 Jun 2026 · NCT06405087Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.